The top 50 medical device companies in the world paid physicians and teaching hospitals $690.3 million last year in general payments, according to an analysis of Medical Design and Outsourcing‘s Big 100 and CMS Open Payments data. Medtech companies averaged $17.3 million in general payments to doctors last year, spending an average of 0.2% of […]
These medical device companies pay doctors the most money
The top medical device companies in the world made more than $542.6 million in general payments to physicians and hospitals in 2018, according to an analysis of Medical Design & Outsourcing‘s Big 100 and CMS Open Payments data. Zimmer Biomet topped the list with $109.4 million in general payments* to physicians and teaching hospitals in […]
Stent makers point to quality-of-life findings by massive federal study
The giant federal study that found the use of stents in stable heart-disease patients is no better than drugs to treat clogged arteries reached another, less-hyped conclusion. Manufacturers of stents for percutaneous coronary intervention (PCI) note that the Ischemia study also concluded that patients who undergo a stenting procedure have a better quality of life. They suffer […]
Study: Stents no better than drugs for stable heart disease
This article has been updated with stock market results and comments from Medtronic. A major new study has concluded that the use of stents in stable heart disease patients is no better than drugs to treat clogged arteries. Results of the Ischemia study were released at the American Heart Association annual meeting in Philadelphia on Saturday. The […]
Report: FDA still hiding reports of patient deaths
This article has been updated with a response from Boston Scientific. The FDA is apparently allowing medtech companies to submit incomplete reports of device-related deaths, according to a new report by the StarTribune of Minneapolis. The news article says that the agency accepted one summary report covering four deaths related to Boston Scientific’s (NYSE:BSX) Watchman […]
Abbott CEO White stepping down in 2020, names successor
Abbott (NYSE:ABT) today announced Miles White will be stepping down as CEO on March 31, 2020, and Robert Ford will succeed him. White has served as Abbott’s president for 21 years and will stay on as the executive chairman of the board after resigning. He mentioned Ford as a possible successor in October 2018. Throughout his […]
Abbott recall of CentriMag circulatory support system designated as Class I
Updated Nov. 6 after FDA edited its notice to update on injury and fatality numbers. The U.S. FDA today issued a Class I designation — its most serious — over Abbott’s recall of its CentriMag circulatory support system. By the time Abbott (NYSE:ABT) initiated a recall in August 2019, there were already reports 44 injuries related […]
Abbott plans $38m Mitraclip plant in Indiana
Abbott (NYSE:ABT) announced yesterday that it plans to spend close to $38 million to open a manufacturing plant for its Mitraclip system in Westfield, Ind. The proposed 120,000-square-foot facility in Westfield’s NorthPoint Industrial Park could cost more than $37.6 million and is slated to employ as many as 477 people by the end of 2024, according […]
Abbott inks inks diabetes tech partnerships with Tandem Diabetes, Omada Health
Abbott (NYSE:ABT) said today that it has entered into an agreement with Tandem Diabetes Care (NSDQ:TNDM) to combine the former’s glucose-sensing technology with the latter’s insulin delivery systems. The news comes one day after Abbott announced a partnership with Omada Health to pair Abbott’s FreeStyle Libre continuous glucose monitoring system with Omada’s digital care program. Get the full story at our […]
SEC settles insider trading cases
The U.S. Securities & Exchange Commission said this week that it settled the case against the final five defendants in an insider trading scheme involving involving large corporate mergers. In August 2017, U.S. authorities accused seven individuals of reaping more than $5 million in illicit profits based on tips from Daniel Rivas, whose work at Bank […]
Study: Abbott, Edwards may have mislabeled hundreds of patient deaths
This report has been updated with comments from Edwards Lifesciences, Madris Tomes and the FDA. Abbott (NYSE:ABT) and Edwards Lifesciences (NYSE:EW) may have mislabeled patient deaths as injuries or device malfunctions in hundreds of FDA adverse event reports involving their transcatheter aortic or mitral valve replacement devices, according to a new study. The study by JAMA […]
- 1
- 2
- 3
- …
- 70
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube